PCV26 COST-EFFECTIVENESS OF EXTENDING PROPHYLAXIS WITH FONDAPARINUX IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING HIP FRACTURE SURGERY
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61670-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)61670-1/fulltext
Section Title :
Section Order :
116
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61670-1&doi=10.1016/S1098-3015(10)61670-1